Home > Annual Financials > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY Financial Statement Analysis
[BOM: 532872|NSE : SPARC]

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .
The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Annual Financial Results
[BOM: 532872|NSE : SPARC]

ConsolidatedMar2024
Mar2023
Operating Income ₹76 Cr₹239 Cr
Operating Expenses ₹140 Cr₹180 Cr
Expenses ₹478 Cr₹453 Cr
Operating Profit (Excl OI) ₹-402 Cr₹-214 Cr
Other Income ₹29 Cr₹11 Cr
Interest ₹1.70 Cr₹7.64 Cr
Depreciation ₹13 Cr₹12 Cr
Profit Before Tax ₹-387 Cr₹-223 Cr
Profit After Tax ₹-387 Cr₹-223 Cr
Consolidated Net Profit ₹-387 Cr₹-223 Cr
Earnings Per Share (Rs)₹-11.93₹-6.86
PAT Margin (%)-512.56-93.22
ROE(%)-121.28-43.41
ROCE(%)-112.35-41.91
Total Debt/Equity(x)0.370.00

Key Financials

Market Cap : ₹ 5,286.1 Cr
Revenue (TTM) : ₹ 71.8 Cr
Net Profit(TTM) : ₹ -342.5 Cr
EPS (TTM) : ₹ -10.6
P/E (TTM) : -

Industry Peers & Returns1W1M1Y
SUN PHARMA ADVANCED RESEARCH COMPANY -1.2% 1.1% -24.3%
SYNGENE INTERNATIONAL 0.3% 2.3% -7%
SAGILITY INDIA -1.7% -14.6% NA
LATENT VIEW ANALYTICS -2.9% -5.3% -21.3%
JUST DIAL -3.9% -7.5% -12.3%
AWFIS SPACE SOLUTIONS -1.9% 8.7% 40.9%
MEDI ASSIST HEALTHCARE SERVICES -1.9% 6.3% -9.1%
JAYKAY ENTERPRISES -5.1% -9.4% 120%
ECOS (INDIA) MOBILITY & HOSPITALITY -7.4% 33.1% NA


SUN PHARMA ADVANCED RESEARCH COMPANY Revenues
[BOM: 532872|NSE : SPARC]

Y-o-Y

-68.36 %

5 Yr CAGR

-68.36 %

Years Revenues % Change
Mar2024 ₹76 Cr
-68.36
Mar2023 ₹239 Cr -


SUN PHARMA ADVANCED RESEARCH COMPANY Operating Profit
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Profit % Change
Mar2024 ₹-402 Cr
Negative
Mar2023 ₹-214 Cr -

Operating Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years Operating Margin% % Change
Mar2024 -532.26%
Negative
Mar2023 -89.65% -

SUN PHARMA ADVANCED RESEARCH COMPANY Profit After Tax
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years Profit After Tax % Change
Mar2024 ₹-387 Cr
Negative
Mar2023 ₹-223 Cr -

PAT Margins
Y-o-Y

Negative

5 Yr CAGR

Negative

Years PAT Margin(%) % Change
Mar2024 -512.56 %
Negative
Mar2023 -93.22 % -

SUN PHARMA ADVANCED RESEARCH COMPANY Earnings Per Share (EPS)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years EPS % Change
Mar2024 ₹-12
Negative
Mar2023 ₹-6.86 -

SUN PHARMA ADVANCED RESEARCH COMPANY Return on Capital Employed (ROCE)
[BOM: 532872|NSE : SPARC]

Y-o-Y

Negative

5 Yr CAGR

Negative

Years ROCE % Change
Mar2024 -112.35%
Negative
Mar2023 -41.91% -

SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex

Current Share Price : ₹162.9
Current MarketCap: ₹ 5,286.1 Cr
Updated EOD on :Jun 16,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-1.2%

1.1%

-24.3%

SENSEX

-0.8%

-0.9%

6.9%

SUN PHARMA ADVANCED RESEARCH COMPANY related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE HEALTHCARE 1.6% 3.8% 20.8%
BSE SMALLCAP -0.9% 6.2% 8.8%
BSE 500 -1% 1.1% 5.2%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 -0.4% 5.6% 10.9%
NIFTY TOTAL MARKET -1% 1.5% 6.1%

You may also like the below Video Courses


FAQ about SUN PHARMA ADVANCED RESEARCH COMPANY Financials


How the annual revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have changed ?

The Revenues of SUN PHARMA ADVANCED RESEARCH COMPANY have decreased by -68.36% YoY .

How the Earnings per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY have changed?

The Earnings Per Share (EPS) of SUN PHARMA ADVANCED RESEARCH COMPANY has decreased by Negative YoY .